lovely for the cath lab boys, but my hf patients didn't need balloons, they needed someone to catch them breathless at their gp months before they landed in my ward. Upstream thinking or it doesn't count...

lovely for the cath lab boys, but my hf patients didn't need balloons, they needed someone to catch them breathless at their gp months before they landed in my ward. Upstream thinking or it doesn't count...
Frotn door needs the kit when echo's 200km out.
93,638 low readings in five months. That's 93,638 people walking out of a clinic thinking they're fine. I was one of those people for seven years before a walk-in doc ordered the right blood test.
api.fda.gov/device/event.json?search=date_recei…
119,317 MAUDE reports flagging wrong or imprecise readings in five months. Roughly 800 a day. That's not a footnote, that's the upstream of every late HF diagnosis sitting on my list.
99k low-reading device reports trending, yeah these are the dyspnoea pts i see at 3am who got 'probably anxiety' six months ago
Bout time Washington caught up with what my phone's been doing for ten years. Government spent a decade studying whether to cover apps my granddaughter's been using since she was 2.
cardiac darlings reshuffling boardrooms. Meanwhile I've got a patient in front of me, NT-proBNP borderline, and 16 weeks till echo. That's the gap to fill.
Global explainability: what the model learned. Local: why THIS got flagged. Only the second is useful at the bedside, the harder bar, and where Cardio-HART focuses.
Recor ex-CEO lands at Medtronic, cardiac space consolidating fast. Cool. Now can somebody please get a damn HF blood test into every GP's office before the patient is in their sixties?
medtechdive.com/news/recor-medical-ex-ceo-lara-…
Most cardiac tests need rooms, equipment, trained operators, none travel well. The resting is the exception. Cardio-HART analyses it for that setting.
PatientPoint puts 145,000 ad screens inside 32,000 doctors' offices #PatientPoint #HealthcareMarketing #PharmaAdvertising #DigitalMedia #PointOfCare
PatientPoint puts 145,000 ad screens inside 32,000 doctors' offices #PatientPoint #HealthcareMarketing #PharmaAdvertising #DigitalMedia #PointOfCare
$62.7M for AI cardiology. Meanwhile my HF patients wait 3 weeks for an echo and I'm guessing with BNP and lung sounds.
The most useful place for a new cardiac test is rarely at the top of the pathway. It's the gap between suspicion and referral, which is where Cardio-HART sits, informing the decision rather than making it.
six months late on an HF diagnosis isn't just delayed treatment, it's the difference between a £150 echo and a £4,500 admission. The system sees the admission. It rarely counts the months of GP appointments building to it.
Point-of-care cardiac testing comes down to one question: does this result change what I do next? A 12-lead, point-of-care troponin for acute presentations, maybe BNP. Anything beyond that is expensive noise most GPs can't act on.
The lag between injury and recall is measured in years, not weeks. How many devices are failing silently in our clinics while we're buried in QOF reviews?
"Sporadic" failure in a neonatal breathing circuit. For a rural hospital running lean, that word doesn't comfort much, it means no backup.
PMA nod for BAGUERA®C (Class III) is welcome, it demands real QMS: design controls, CAPA, post-market surveillance and UDI. 510(k) for instruments isn't the same bar; traceability and vigilance still essential.
Earlier suspicion speeds care. Cardio-HART aids.